Graypoint LLC Abbott Laboratories Transaction History

Graypoint LLC

$1.52 Billion
Q3 2024

A detailed history of Graypoint LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Graypoint LLC holds 42,737 shares of ABT stock, worth $4.85 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

42,737

Previous 42,442 0.7%

Holding current value

$4.85 Million

Previous $4.41 Million 10.48%

% of portfolio

0.32%

Previous 0.31%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$100.07 - $118.13 $29,520 - $34,848	295 Added 0.7%	42,737 $4.87 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $898,209 - $1 Million	-8,917 Reduced 17.36%	42,442 $4.41 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $179,722 - $198,495	1,641 Added 3.3%	51,359 $5.84 Million
Q4 2023 Jan 29, 2024	SELL	$90.19 - $110.4 $216,275 - $264,739	-2,398 Reduced 4.6%	49,718 $5.47 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $69,259 - $83,099	725 Added 1.41%	52,116 $5.05 Million
Q2 2023 Jul 21, 2023	SELL	$100.78 - $112.29 $596,113 - $664,195	-5,915 Reduced 10.32%	51,391 $5.6 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $1.41 Million - $1.67 Million	-14,606 Reduced 20.31%	57,306 $5.8 Million
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $353,623 - $414,854	-3,720 Reduced 4.92%	71,912 $7.9 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $2,515 - $2,912	-26 Reduced 0.03%	75,632 $7.32 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $80,533 - $97,338	-789 Reduced 1.03%	75,658 $8.22 Million
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $18,813 - $22,941	165 Added 0.22%	76,447 $9.05 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $50,024 - $61,252	433 Added 0.57%	76,282 $10.7 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $372,845 - $412,475	3,196 Added 4.4%	75,849 $8.96 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $213,484 - $251,301	-2,018 Reduced 2.7%	72,653 $8.42 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $629,312 - $741,425	-5,782 Reduced 7.19%	74,671 $8.95 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $822,045 - $895,794	-7,829 Reduced 8.87%	80,453 $8.81 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $576,232 - $699,791	-6,288 Reduced 6.65%	88,282 $9.61 Million
Q2 2020 Jul 30, 2020	BUY	$76.57 - $98.0 $157,427 - $201,488	2,056 Added 2.22%	94,570 $8.65 Million
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $5.81 Million - $8.5 Million	92,514 New	92,514 $7.3 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account